If high cholesterol is increasing your risk of a heart attack, one treatment option includes PCSK9 inhibitors. In this video, learn how PCSK9 inhibitors work to improve cholesterol and reduce the risk of a heart attack, according to Eugenia Gianos, MD, Clinical Cardiologist at Lenox Hill Hospital, Northwell Health.
Eugenia Gianos, MD, is a clinical cardiologist at Lenox Hill Hospital, Northwell Health.
References
American Heart Association. (2020). Cholesterol Medications.
Amgen USA. (2025). Repatha [package insert]. DailyMed.
Centers for Disease Control and Prevention. (2024). Treat and manage familial hypercholesterolemia.
Moşteoru, S., et al. (2020). An update on PCSK9 inhibitors- pharmacokinetics, drug interactions, and toxicity. Expert Opinion on Drug Metabolism & Toxicology.
Pokhrel, B., et al. (2024). PCSK9 inhibitors. StatPearls.
Zhao, Z., et al. (2018). Comparative efficacy and safety of lipid-lowering agents in patients with hypercholesterolemia: A frequentist network meta-analysis. Medicine.
Why trust our experts?
